Quantum Computing earnings date
Quantum Computing (QUBT) Q3 2026 Earnings Report
MX:QUBT Q3 2026 EPS Results
- Actual EPS
- -MXN 1.30
- Consensus EPS
- -MXN 0.74
- Beat/Miss
- Missed by -MXN 0.56
- One Year Ago EPS
- MXN 0.19
MX:QUBT Q3 2026 Revenue Results
- Actual Revenue
- MXN 176.70M
- Expected Revenue
- MXN 141.53M
- Beat/Miss
- Beat by +MXN 35.17M
- YoY Revenue Growth
- +2373.96%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/09/2026
- Time
- After Close
- Conference Call
- Monday, November 9, 2026
Quantum Computing's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was broadly optimistic, supported by record revenue, strong liquidity, acquisitions that expanded the commercial and manufacturing base, progress on the Dirac-3 launch, and stated advances toward scalable quantum manufacturing. However, the company continues to report a substantial net loss, a 4.5% gross margin, sharply higher operating expenses, lumpy order timing, government and aerospace concentration, and an early-stage commercialization profile. Overall, the positive operational and strategic developments outweighed the financial and execution challenges.
QCI expects the first customer shipment of Dirac-3 during the fourth quarter, with capacity for up to 9.98 thousand variables, and is focused over the next 12 to 24 months on growing its commercial business, scaling manufacturing, and advancing its quantum portfolio. Over the next 12-18 months, it expects to continue growing business opportunities and revenue, expanding manufacturing, and pushing its technology; it is not giving guidance at this time, but over say, 12-15 months, management is confident it will have a strong finish to this year and a solid backlog going on leading into 2027. Backlog typically will burn off over between 12 to 18 months, with most of it likely to be converted to revenue in the next 12 months, and the current mix is government, aerospace and commercial space, yes, largely aerospace, and government probably 70-ish percent, with an expectation over time to be closer to 50%. The current OpEx level is a pretty good estimate of where QCI is right now, with the third quarter number probably a pretty good predictor for the next quarter; increases are expected as headcount grows, but not dramatic. QCI expects to demonstrate heterogeneous integrated circuits in the timeframe of 12 to 18 months, and it could be shorter; its initial greenfield plan for Fab 2 was expected to complete step 2 maybe at the end of 2028, while the Enhanced acquisition has accelerated that road map quite a lot. Management earmarked several hundred million dollars for capital, CapEx, including $70 million to $80 million for Enhanced Fab 2, with a lot of that spend taking place between now and March 31 of next year, end of the second quarter.
- Record Third-Quarter RevenueQ3 revenue reached a record $9.5 million, up from $384 thousand in the same period last year. Q3 revenue also exceeded the $9.2 million generated during the entire first half of 2026, with sales primarily driven by photonic products serving aerospace, government and industrial applications.
- Acquisitions Expanded the Commercial FoundationThe acquisitions completed earlier in the year added established products, customer relationships, manufacturing capabilities and commercial operations, while also supporting QCI's longer-term quantum technology road map.
- Quantum Customer and Partner ProgressQCI provided cloud access to its Dirac system to Hamad Khalifa University in Qatar, installed a Dirac optimization system at a leading global consulting firm, and agreed to work with Planck Dynamics on its neural wave reservoir computer for defense applications.
- Dirac-3 Launch and Capacity ExpansionQCI announced its next-generation Dirac-3 quantum optimization machine, designed to solve optimization problems with up to 9.98 thousand variables. The company expects the first customer shipment during the fourth quarter and said Dirac-3 supports both cloud access and on-premise orders.
- Encouraging Dirac-3 Benchmark ResultsQCI published benchmark results comparing Dirac-3 with Hexaly and other leading classical optimization algorithms. Management said Dirac-3 performed better on most tested problems in both time to solution and solution quality, while acknowledging that some problems were comparable or less optimal.
- Dirac-3 Customer Reception and Pipeline PotentialManagement reported very positive feedback on Dirac-3's expanded variable capacity and solution quality, with online customers reportedly surprised by its performance. Existing Dirac-2 customers may upgrade to Dirac-3, while the higher capacity and performance could attract customers in additional application areas.
- Expansion into Biotech and Clinical ResearchThe collaboration with ImmuBio is exploring the use of direct optimization AI and conventional analytics for clinical research data. Management also cited potential applications in drug discovery, patient scheduling and clinical trial studies involving biomarkers and Phase 1, Phase 2 and Phase 3 studies.
- Quantum Photonics Platform and Manufacturing InfrastructureQCI's platform extends beyond computing into sensing and communications. The company is combining photonic design, chip manufacturing and advanced packaging at its North Carolina and Arizona facilities to support proprietary quantum systems and established photonics markets.
- Completion of the 2024-2026 Portfolio Road MapManagement stated that QCI achieved all objectives outlined in its 2024-2026 portfolio road map and is now moving into a phase focused on scaling manufacturing and product lines. The stated goal is to make quantum systems smaller, more capable and easier to deploy.
- Manufacturing Integration and Scale-Up PrioritiesOver the next 12 to 24 months, QCI plans to grow its commercial business, scale manufacturing and advance its quantum portfolio. The company is integrating operations across 8 states and 11 facilities, improving coordination between sites rather than consolidating facilities.
- Fab 2 Timeline AccelerationQCI said its original greenfield plan for Fab 2 targeted completion around the end of 2028. The Enhanced acquisition accelerated that road map, and management said the company is building on Enhanced's advanced-packaging capabilities to expand manufacturing capacity and support quantum products.
- Progress Toward Heterogeneously Integrated CircuitsQCI's internal photonic integrated-circuit engineering team is working with the Enhanced manufacturing team, and management expects to demonstrate heterogeneous integrated circuits within 12 to 18 months, possibly sooner.
- Strong Liquidity and Balance SheetQCI ended the quarter with approximately $1.3 billion in cash, cash equivalents and investments, approximately $1.6 billion in total assets, $47.7 million in total liabilities and approximately $916.9 million in working capital. Management believes liquidity is sufficient to fund operations for at least the next 12 months.
- Contract Backlog Provides Revenue FoundationContract backlog was approximately $39.1 million at quarter end. Management said backlog typically burns off over 12 to 18 months, with most expected to convert to revenue in the next 12 months, although some deliveries may take longer because the products are technologically complex.
- Interest Income IncreasedInterest and other income totaled $13 million in Q3, compared with $3.5 million in the prior-year period, primarily reflecting interest earned on larger cash and investment balances.
- Planned Capital Investment in Fab 2Management said several hundred million dollars had been earmarked for capital expenditures and investments, including approximately $70 million to $80 million for the Enhanced Fab 2. Equipment ordering has begun, with a significant portion of that spending expected between the quarter and March 31 of next year.
- Room-Temperature Photonics ApproachManagement highlighted that QCI's Dirac systems operate at room temperature, have relatively low power requirements and do not require the specialized cryogenic infrastructure used by many other approaches. Management said these characteristics can reduce cost and complexity.
- Potential Data-Center Optimization OpportunityQCI's internal research into applying Dirac optimization to improve compute-resource utilization in data centers was described as encouraging. Management said this could create an opportunity to provide more compute resources without building new data centers, while also noting that the opportunity remains subject to further evaluation.
MX:QUBT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -1.26- | -0.19 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.74-1.30 | 0.19 | -800.00% (-1.49) | |
| Aug 10, 2026 | 2026 (Q2) | -0.65-0.93 | -4.84 | 80.77% (+3.91) | |
| May 11, 2026 | 2026 (Q1) | -0.87-0.37 | 2.05 | -118.18% (-2.42) | |
| Mar 02, 2026 | 2025 (Q4) | -0.63-0.19 | -8.74 | 97.87% (+8.56) | |
| Nov 14, 2025 | 2025 (Q3) | -1.060.19 | -1.12 | 116.67% (+1.30) | |
| Aug 14, 2025 | 2025 (Q2) | -1.02-4.84 | -1.12 | -333.33% (-3.72) | |
| May 15, 2025 | 2025 (Q1) | -1.302.05 | -1.49 | 237.50% (+3.53) | |
| Mar 20, 2025 | 2024 (Q4) | -0.93-8.74 | -1.67 | -422.22% (-7.07) | |
| Nov 06, 2024 | 2024 (Q3) | ―- | -1.67 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
